268 related articles for article (PubMed ID: 24576884)
21. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
22. Investigating
Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
[No Abstract] [Full Text] [Related]
23. Telomere shortening is a hallmark of genetic cardiomyopathies.
Chang ACY; Chang ACH; Kirillova A; Sasagawa K; Su W; Weber G; Lin J; Termglinchan V; Karakikes I; Seeger T; Dainis AM; Hinson JT; Seidman J; Seidman CE; Day JW; Ashley E; Wu JC; Blau HM
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9276-9281. PubMed ID: 30150400
[TBL] [Abstract][Full Text] [Related]
24. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.
Ye L; Ni X; Zhao ZA; Lei W; Hu S
J Cardiovasc Transl Res; 2018 Oct; 11(5):366-374. PubMed ID: 29845439
[TBL] [Abstract][Full Text] [Related]
25. Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
Bermúdez-Jiménez FJ; Carriel V; Brodehl A; Alaminos M; Campos A; Schirmer I; Milting H; Abril BÁ; Álvarez M; López-Fernández S; García-Giustiniani D; Monserrat L; Tercedor L; Jiménez-Jáimez J
Circulation; 2018 Apr; 137(15):1595-1610. PubMed ID: 29212896
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cells in cardiovascular drug discovery.
Mercola M; Colas A; Willems E
Circ Res; 2013 Feb; 112(3):534-48. PubMed ID: 23371902
[TBL] [Abstract][Full Text] [Related]
27. New insights into the pathology of inherited cardiomyopathy.
Hughes SE; McKenna WJ
Heart; 2005 Feb; 91(2):257-64. PubMed ID: 15657260
[No Abstract] [Full Text] [Related]
28. Modeling of
Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
[TBL] [Abstract][Full Text] [Related]
29. Generation of an induced pluripotent stem cell line from a patient with arrhythmogenic right ventricular cardiomyopathy harboring a TMEM43 splice-site variant.
Lee SH; Lim G; Kim H; Suh D; Choi HK; Kim HP; Yoon HG; Park SW; Kang SM; Kwon C; Oh J; Lee SH
Stem Cell Res; 2024 Aug; 78():103453. PubMed ID: 38824800
[TBL] [Abstract][Full Text] [Related]
30. Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies.
Turnbull IC; Mayourian J; Murphy JF; Stillitano F; Ceholski DK; Costa KD
Methods Mol Biol; 2018; 1816():145-159. PubMed ID: 29987817
[TBL] [Abstract][Full Text] [Related]
31. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T; Mummery C; Knollmann BC
Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
[TBL] [Abstract][Full Text] [Related]
32. Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.
Kumar S; Curran JE; Kumar K; DeLeon E; Leandro AC; Peralta J; Williams-Blangero S; Blangero J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805011
[TBL] [Abstract][Full Text] [Related]
33. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Hershberger RE; Cowan J; Morales A; Siegfried JD
Circ Heart Fail; 2009 May; 2(3):253-61. PubMed ID: 19808347
[TBL] [Abstract][Full Text] [Related]
34. Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system.
Kang JY; Mun D; Chun Y; Park DS; Kim H; Yun N; Lee SH; Joung B
Stem Cell Res; 2022 Oct; 64():102901. PubMed ID: 36037555
[TBL] [Abstract][Full Text] [Related]
35. The genetic basis for cardiac remodeling.
Ahmad F; Seidman JG; Seidman CE
Annu Rev Genomics Hum Genet; 2005; 6():185-216. PubMed ID: 16124859
[TBL] [Abstract][Full Text] [Related]
36. Animal models of arrhythmogenic cardiomyopathy.
McCauley MD; Wehrens XH
Dis Model Mech; 2009; 2(11-12):563-70. PubMed ID: 19892887
[TBL] [Abstract][Full Text] [Related]
37. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
38. Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models.
Granéli C; Hicks R; Brolén G; Synnergren J; Sartipy P
Stem Cell Rev Rep; 2019 Feb; 15(1):13-22. PubMed ID: 30343468
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
Wyles SP; Hrstka SC; Reyes S; Terzic A; Olson TM; Nelson TJ
Clin Transl Sci; 2016 Jun; 9(3):158-67. PubMed ID: 27105042
[TBL] [Abstract][Full Text] [Related]
40. Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.
Goedel A; My I; Sinnecker D; Moretti A
Curr Cardiol Rep; 2017 Mar; 19(3):23. PubMed ID: 28220464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
